Biopharma
Biosimilar Collaborations Ireland Ltd
Biosimilar marketing authorisation holder
Displayed brand : Biocon Biologics
About Biosimilar Collaborations Ireland Ltd
Biosimilar Collaborations Ireland Limited is an Irish company within Biocon Biologics. Its official report establishes ownership through Biocon Biologics UK, itself a group subsidiary.
The European Medicines Agency identifies it as the marketing authorisation holder for Hulio, an adalimumab biosimilar. The catalogue’s shortened “Biosimilar Ireland” label is linked to this identity, separately from Biocon Biologics France SAS.
Official sources
- EMA — titulaire de Hulio
- Biocon — identité et appartenance au groupe de Biosimilar Collaborations Ireland
Information checked 10 November 2026
Logo sourceAssociated catalogue products
These products are linked to this organisation in the catalogue as a laboratory or supplier. Refer to each product page for its documented manufacturer or operator. Purchasing terms and ordering are available through your professional account.
The product list is temporarily unavailable.
Try againYour professional shop
Open the shop to sign in, view the terms available to your account and place your order.
Open the shop